Letters
Weight loss drugs for unemployed people
Prioritising patients back to work: a small step for NICE, a giant leap for the NHS
BMJ 2024; 387 doi: https://doi.org/10.1136/bmj.q2841 (Published 23 December 2024) Cite this as: BMJ 2024;387:q2841
- Audun Brendbekken, PhD candidate,
- Anand Bhopal, researcher
- Bergen Centre for Ethics and Priority Setting in Health (BCEPS), University of Bergen, 5009 Bergen, Norway
- audun.brendbekken{at}uib.no
Announcing investments in a five year trial of tirzepatide (a glucagon-like peptide-1 analogue weight loss drug), health secretary Wes Streeting showed support for prioritising patients able to return to work, saying that obesity was not only a health issue but also “holding back our economy.”12 Incorporating the economic benefits of returning people to work sooner echoes concerns raised in the Darzi report, commissioned by Streeting. …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.